Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Boehringer Ingelheim Biopharmaceutical Production

Order year

2003

Project type

New biopharmaceutical manufacturing facility

Location

Vienna, Austria

Estimated investment

€80 million

Completion

Construction complete in April 2005, validation completed by the end of 2005

Output chemicals

Therapeutic proteins, Plasmid DNA, monoclonal antibodies

Sponsor

Boehringer Ingelheim Austria

Designer

Lorenz Consult

Contractors

Bia Separations, M+W Zander

Financing

Boehringer Ingelheim
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top